Coherus Biosciences | Spese Operative

Prezzo Delle Azioni
2.15
Cambio Giornaliero
0.09 4.13%
Mensile
30.00%
Annuale
93.24%
Q1 Previsione
2.39




Spese Operative Cambiamento Data
AbbVie USD 10.81B 13.45B 2025-12
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Akebia Therapeutics USD 43.82M 16.98M 2025-03
ALKERMES USD 1.73B 1.44B 2025-09
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Amarin USD 51.37M 14.6M 2025-09
Amgen USD 5.9B 773M 2025-12
Baxter International USD 2.63B 95.8M 2025-09
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Coherus Biosciences USD 53.03M 43.41M 2025-03
Eli Lilly USD 10.31B 1.09B 2025-12
Fujifilm JPY 767.39B 27.7B 2025-12
Gilead Sciences USD 4.26B 95M 2025-09
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Merck USD 10.16B 558M 2025-12
Myriad Genetics USD 229M 3.4M 2025-09
Pacira USD 166.36M 4.5M 2025-09
Perrigo USD 949.9M 50.8M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
PTC Therapeutics USD 207.52M 6.21M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
Vertex Pharmaceuticals USD 1.84B 27.1M 2025-09
Xencor USD 68.52M 8.26M 2025-09
Zoetis USD 5.4B 3.94B 2025-09


Coherus Biosciences Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.